Premium
Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease – authors' reply
Author(s) -
Rosen M. J.,
Minar P.,
Vinks A. A.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13262
Subject(s) - infliximab , adalimumab , medicine , ulcerative colitis , crohn's disease , monoclonal antibody , gastroenterology , tumor necrosis factor alpha , vedolizumab , inflammatory bowel disease , monoclonal , disease , immunology , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom